General MedicationsORALStandard

MONTELUKAST SODIUM

Standard Dose

EQ 10MG BASE

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: Prescription

Summary

Approval overview MONTELUKAST SODIUM is listed in Drugs@FDA under application 209012 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient MONTELUKAST SODIUM Form and strength TABLET;ORAL - EQ 10MG BASE Sponsor RISING Submission history Latest submission status date: 2024-05-17 00:00:00.

Structured Monograph

Clinical summary

Approval overview MONTELUKAST SODIUM is listed in Drugs@FDA under application 209012 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient MONTELUKAST SODIUM Form and strength TABLET;ORAL - EQ 10MG BASE Sponsor RISING Submission history Latest submission status date: 2024-05-17 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Prescription
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.